Beryl Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 11 May 2026.

Beryl Drugs will hold a meeting of the Board of Directors of the Company on 1 April 2026.Powered by Capital Market - Live News

Beryl Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 16 March 2026.Powered by Capital Market - Live News

Net loss of Beryl Drugs reported to Rs 0.17 crore in the quarter ended December 2025 as against net profit of Rs 0.05 crore during the previous quarter ended December 2024. Sales declined 28.81% to Rs 3.78 crore in the quarter ended December 2025 as against Rs 5.31 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales3.785.31 -29 OPM %-5.2910.92 - PBDT-0.290.46 PL PBT-0.610.15 PL NP-0.170.05 PL Powered by Capital Market - Live News

Beryl Drugs will hold a meeting of the Board of Directors of the Company on 9 February 2026.Powered by Capital Market - Live News